Valuation: Getinge AB

Market Cap 65.4B 6.87B 5.94B 5.58B 5.07B 9.53B 655B 9.7B 25.56B 329B 25.77B 25.24B 1,103B P/E 2026 *
21.2x
P/E 2027 * 18.9x
Enterprise Value 73.96B 7.77B 6.71B 6.31B 5.74B 10.78B 741B 10.96B 28.9B 372B 29.15B 28.54B 1,247B EV / Sales 2026 *
2.1x
EV / Sales 2027 * 1.93x
Free-Float
78.61%
Yield 2026 *
2.16%
Yield 2027 * 2.35%
1 week+0.37%
Current month+1.25%
1 month+15.93%
3 months+22.95%
6 months+15.20%
Current year+7.86%
1 week 21.52
Extreme 21.52
21.96
1 month 18.29
Extreme 18.29
21.98
3 years 14.2
Extreme 14.2
21.98
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 2017-04-30
Director of Finance/CFO 48 2024-03-30
Compliance Officer 47 2020-09-30
Director TitleAgeSince
Chairman 65 2019-04-22
Chairman 75 -
Director/Board Member 70 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+0.51%+21.38%+36.65% 6.88B
+0.08%+0.73%+29.25%+25.72% 12.88B
+0.08%+1.31%+17.06%+28.98% 6.88B
-0.97%+5.01%+46.63%+41.21% 6.46B
+0.65%+2.81% - - 5.66B
+0.14%+4.47%-26.77%+50.40% 4.56B
-1.67%-3.33%-25.92%-22.81% 3.91B
-2.47%+3.42%+44.50%-45.85% 1.97B
-1.94%+1.08%+61.58%-6.29% 1.71B
-2.80%-11.09%-28.92%+120.76% 1.55B
Average -0.99%+2.13%+15.42%+25.42% 5.06B
Weighted average by Cap. -0.43%+2.06%+18.53%+27.25%

Financials

2026 *2027 *
Net sales 35.16B 3.7B 3.19B 3B 2.73B 5.12B 352B 5.21B 13.74B 177B 13.86B 13.57B 593B 37.08B 3.9B 3.37B 3.17B 2.88B 5.4B 372B 5.5B 14.49B 187B 14.61B 14.31B 625B
Net income 3.09B 324M 280M 263M 239M 450M 30.92B 458M 1.21B 15.52B 1.22B 1.19B 52.04B 3.46B 363M 314M 295M 268M 504M 34.64B 513M 1.35B 17.39B 1.36B 1.33B 58.3B
Net Debt 8.56B 900M 777M 731M 664M 1.25B 85.77B 1.27B 3.35B 43.06B 3.37B 3.3B 144B 6.33B 665M 575M 540M 491M 922M 63.41B 938M 2.47B 31.83B 2.49B 2.44B 107B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
26-08-14 €21.83 +0.05%
26-08-13 €21.82 +0.32%
26-08-12 €21.75 -0.14%
26-08-11 €21.78 +0.14%
26-08-10 €21.75 0.00%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
240.10SEK
Average target price
237.90SEK
Spread / Average Target
-0.92%

Quarterly revenue - Rate of surprise